aluates Reports

$ 0.0

Automative

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-31K13063

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon DEB Catheters Market Research Report 2023

BUY CHAPTERS

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Research Report 2026

Code: QYRE-Auto-31K13063

Report

2026-01-21

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size

The global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market was valued at US$ 709 million in 2025 and is anticipated to reach US$ 1738 million by 2032, at a CAGR of 13.5% from 2026 to 2032.

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Percutaneous Transluminal Coronary Angioplasty (PTCA) drug-eluting balloon (DEB) catheters—often referred to as coronary drug-coated balloon (DCB) catheters—are drug–device combination angioplasty systems used in PTCA. The balloon surface is coated with an antiproliferative drug (commonly paclitaxel, with growing “limus” exploration) plus an excipient/carrier matrix. During inflation, the catheter provides immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia, thereby reducing restenosis and repeat interventions. The strategic proposition is “leave nothing behind,” avoiding additional permanent metal/polymer layers—particularly valuable in coronary in-stent restenosis (ISR), small vessels, and selected bifurcation strategies—while increasingly integrating lesion preparation and intravascular imaging into a repeatable coronary repair pathway.In 2025, global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters production reached approximately 755 k units and price is 940 USD/Unit.The average gross profit margin of this product is 73%.

Commercial certainty has strengthened materially for coronary DEB/DCB catheters. The U.S. FDA’s 2024 approval of Boston Scientific’s AGENT™ coronary DCB for ISR marked a watershed moment, effectively opening a compliant U.S. pathway for coronary DCB therapy. In parallel, Europe’s long-standing practice and guideline endorsement have reinforced replicability—major editorial commentary highlights broad European adoption and high-level guideline support for ISR use. For industry leaders, this is not merely a device win; it signals category expansion driven by evidence and compliance—shifting competition from a single product to a system-level value delivery around lesion selection, standardized technique, and discipline-building.

Constraints are defined by indication boundaries and reproducible engineering. In previously untreated, non-complex coronary artery disease, drug-coated balloon angioplasty has not been positioned as a straightforward default replacement for contemporary stenting strategies in recent reported evidence, underscoring the need for tighter lesion stratification and procedural standardization as adoption expands. As a drug–device combination, coronary DCBs are highly sensitive to coating integrity, particulate control, dose uniformity, and deliverability—where variability can quickly translate into clinical experience gaps and access risk, raising the bar for quality systems, supply stability, and lifecycle risk management.

Demand is moving from “device choice” to “repair solutions.” Hospitals and operators increasingly prioritize avoiding additional metal layers in ISR and reducing the complexity of future reinterventions—driving more routine integration of DEB/DCB with lesion preparation and intravascular imaging (IVUS/OCT), and repositioning the catheter from a consumable to a pathway tool. Reimbursement signals are also turning constructive: CMS has granted an add-on payment pathway for AGENT DCB use in eligible inpatient settings, supporting more structured hospital adoption and resource planning. Meanwhile, innovation is diversifying—“limus”-based and low-/no-excipient approaches continue to progress with regulatory milestones in certain markets, accelerating multi-route iteration beyond a single drug platform.

Upstream differentiation is ultimately a “materials–coating–validation” platform capability rather than a simple bill of materials. Core inputs include balloon films and catheter polymers (multi-durometer shafts, liners, reinforcement braids/coils), drug APIs (paclitaxel or limus agents) with crystallinity/particle control, excipient and solvent systems, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Coronary use is especially sensitive to deliverability and safety, forcing the supply chain to industrialize coating stability, particulate control, dose uniformity, and batch-release consistency as durable engineering capabilities that underpin long-term brand and channel credibility.

This report delivers a comprehensive overview of the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters. The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Report

Report Metric	Details
Report Name	Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market
Accounted market size in 2025	US$ 709 million
Forecasted market size in 2032	US$ 1738 million
CAGR	13.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Paclitaxel-based limus Other
Segment by Use Scenario	In-Stent Restenosi De Novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Hospitals Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B. Braun, Eurocor, Teleflex, Yinyi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market growing?

Ans: The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market witnessing a CAGR of 13.5% during the forecast period 2026-2032.

What is the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market size in 2032?

Ans: The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market size in 2032 will be US$ 1738 million.

Who are the main players in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The main players in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market are B. Braun, Eurocor, Teleflex, Yinyi

What are the Application segmentation covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The Applications covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The Types covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report are Paclitaxel-based, limus, Other

1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Overview

1.1 Product Definition

1.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type

1.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Type: 2025 vs 2032

1.2.2 Paclitaxel-based

1.2.3 limus

1.2.4 Other

1.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Use Scenario

1.3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De Novo

1.3.4 Small Vessel

1.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Balloon Platform Mechanics

1.4.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application

1.5.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Others

1.6 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Estimates and Forecasts

1.6.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue 2021–2032

1.6.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales 2021–2032

1.6.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competition by Manufacturers

2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Manufacturers (2021–2026)

2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Product Types and Applications

2.7 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Date of Entry into the Industry

2.8 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competitive Situation and Trends

2.8.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Players Market Share by Revenue

2.8.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Scenario by Region

3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2021–2032

3.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2021–2026

3.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2027–2032

3.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2021–2032

3.3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2021–2026

3.3.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2027–2032

3.4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.4.1 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2021–2032)

3.4.3 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.4.6 Mexico

3.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.5.1 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2021–2032)

3.5.3 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Region

3.6.1 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2021–2032)

3.6.3 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.7.1 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2021–2032)

3.7.3 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.8.1 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2021–2032)

3.8.3 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2021–2032)

4.1.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2021–2026)

4.1.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2027–2032)

4.1.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2021–2032)

4.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2021–2032)

4.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2021–2026)

4.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2027–2032)

4.2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2021–2032)

4.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price by Type (2021–2032)

5 Segment by Application

5.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2021–2032)

5.1.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2021–2026)

5.1.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2027–2032)

5.1.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2021–2032)

5.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2021–2032)

5.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2021–2026)

5.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2027–2032)

5.2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2021–2032)

5.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price by Application (2021–2032)

6 Key Companies Profiled

6.1 B. Braun

6.1.1 B. Braun Company Information

6.1.2 B. Braun Description and Business Overview

6.1.3 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.1.5 B. Braun Recent Developments/Updates

6.2 Eurocor

6.2.1 Eurocor Company Information

6.2.2 Eurocor Description and Business Overview

6.2.3 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.2.5 Eurocor Recent Developments/Updates

6.3 Teleflex

6.3.1 Teleflex Company Information

6.3.2 Teleflex Description and Business Overview

6.3.3 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.3.5 Teleflex Recent Developments/Updates

6.4 Yinyi

6.4.1 Yinyi Company Information

6.4.2 Yinyi Description and Business Overview

6.4.3 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.4.5 Yinyi Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain Analysis

7.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Mode & Process Analysis

7.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales and Marketing

7.4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Channels

7.4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Distributors

7.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Customer Analysis

8 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Dynamics

8.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Trends

8.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers

8.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Challenges

8.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competitive Situation by Manufacturers in 2025

Table 6. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Product Types and Applications

Table 14. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies by Tier (Tier 1, Tier 2, Tier 3), based on Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (K Units), 2021–2026

Table 20. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2021–2026)

Table 21. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (K Units), 2027–2032

Table 22. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2027–2032)

Table 23. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (US$ Million), 2021–2026

Table 24. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2021–2026)

Table 25. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (US$ Million), 2027–2032

Table 26. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2027–2032)

Table 27. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2021–2026

Table 29. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2027–2032

Table 30. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2021–2026

Table 31. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2021–2026

Table 34. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2027–2032

Table 35. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2021–2026

Table 44. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2027–2032

Table 45. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (US$ Million), 2027–2032

Table 52. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units) by Type (2021–2026)

Table 53. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units) by Type (2027–2032)

Table 54. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2021–2026)

Table 55. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2027–2032)

Table 56. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2021–2026)

Table 59. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2027–2032)

Table 60. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Type (2021–2026)

Table 61. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Type (2027–2032)

Table 62. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units) by Application (2021–2026)

Table 63. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units) by Application (2027–2032)

Table 64. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2021–2026)

Table 65. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2027–2032)

Table 66. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2021–2026)

Table 69. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2027–2032)

Table 70. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Application (2021–2026)

Table 71. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Application (2027–2032)

Table 72. B. Braun Company Information

Table 73. B. Braun Description and Business Overview

Table 74. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. B. Braun Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 76. B. Braun Recent Developments/Updates

Table 77. Eurocor Company Information

Table 78. Eurocor Description and Business Overview

Table 79. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Eurocor Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 81. Eurocor Recent Developments/Updates

Table 82. Teleflex Company Information

Table 83. Teleflex Description and Business Overview

Table 84. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Teleflex Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 86. Teleflex Recent Developments/Updates

Table 87. Yinyi Company Information

Table 88. Yinyi Description and Business Overview

Table 89. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Yinyi Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 91. Yinyi Recent Developments/Updates

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Distributors List

Table 95. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Customers List

Table 96. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Trends

Table 97. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers

Table 98. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Challenges

Table 99. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Restraints

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Product Picture of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters

Figure 2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Type: 2025 & 2032

Figure 4. Paclitaxel-based Product Picture

Figure 5. limus Product Picture

Figure 6. Other Product Picture

Figure 7. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Use Scenario (US$ Million), 2021–2032

Figure 8. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Use Scenario: 2025 vs 2032

Figure 9. In-Stent Restenosi Product Picture

Figure 10. De Novo Product Picture

Figure 11. Small Vessel Product Picture

Figure 12. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 13. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 14. Semi-/Compliant Product Picture

Figure 15. Non-compliant Product Picture

Figure 16. Other Product Picture

Figure 17. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application (US$ Million), 2021–2032

Figure 18. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Application: 2025 & 2032

Figure 19. Hospitals

Figure 20. Clinics

Figure 21. Others

Figure 22. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size (US$ Million), 2021–2032

Figure 24. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (K Units), 2021–2032

Figure 25. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (US$/Unit), 2021–2032

Figure 26. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Report Years Considered

Figure 27. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Share by Manufacturers in 2025

Figure 28. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Players: Market Share by Revenue in Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2025

Figure 30. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2021–2032)

Figure 33. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2021–2032)

Figure 34. United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2021–2032)

Figure 38. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2021–2032)

Figure 39. Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. UK Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Italy Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Russia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2021–2032)

Figure 45. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2021–2032)

Figure 46. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Australia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. China Taiwan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Indonesia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Thailand Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Malaysia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2021–2032)

Figure 56. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2021–2032)

Figure 57. Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Argentina Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2021–2032)

Figure 61. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2021–2032)

Figure 62. Turkey Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Saudi Arabia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. UAE Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. Global Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type (2021–2032)

Figure 66. Global Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type (2021–2032)

Figure 67. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Type (2021–2032)

Figure 68. Global Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application (2021–2032)

Figure 69. Global Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application (2021–2032)

Figure 70. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (US$/Unit) by Application (2021–2032)

Figure 71. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Value Chain

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License